| abrdn Healthcare Investors |
HQH |
🇺🇸 |
New York Stock Exchange |
$943mn |
|
| abrdn Healthcare Opportunities Fund |
THQ |
🇺🇸 |
New York Stock Exchange |
$881mn |
|
| Ambu AS - Class B Shares |
AMBU B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.31.9bn |
STOXX600 |
| Augmedix Inc |
AUGX |
🇺🇸 |
NASDAQ |
$111mn |
|
| Avita Medical Limited |
AVH |
🇦🇺 |
Australian Stock Exchange |
AU$963mn |
|
| Baxter International Inc. |
BAX |
🇺🇸 |
New York Stock Exchange |
$17.9bn |
S&P 100 S&P 500 |
| Bellevue Healthcare Trust Plc |
BBH |
🇬🇧 |
London Stock Exchange |
£687mn |
|
| Cardinal Health, Inc. |
CAH |
🇺🇸 |
New York Stock Exchange |
$23.6bn |
S&P 500 |
| CareCloud Inc |
MTBC |
🇺🇸 |
NASDAQ |
$34mn |
|
| CareTech Holdings Plc |
CTH |
🇬🇧 |
London Stock Exchange |
£850mn |
|
| Centene Corp. |
CNC |
🇺🇸 |
New York Stock Exchange |
$36.0bn |
S&P 500 |
| Cerner Corp. |
CERN |
🇺🇸 |
NASDAQ |
$27.9bn |
NASDAQ 100 S&P 500 |
| Chr. Hansen Holding |
CHR |
🇩🇰 |
Copenhagen Stock Exchange |
kr.72.5bn |
OMX Copenhagen 20 STOXX600 |
| Cigna Group (The) |
CI |
🇺🇸 |
New York Stock Exchange |
$96.9bn |
S&P 500 |
| Clariane SE |
CLARI |
🇫🇷 |
Euronext Paris |
€643mn |
|
| Clinica Baviera |
CBAV |
🇪🇸 |
Madrid Stock Exchange |
€486mn |
|
| Coloplast AS - Class B Shares |
COLO B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.187.8bn |
STOXX600 OMX Copenhagen 20 |
| Cooper Companies, Inc. |
COO |
🇺🇸 |
NASDAQ |
$18.5bn |
S&P 500 |
| Craneware Plc |
CRW |
🇬🇧 |
London Stock Exchange |
£830mn |
|
| Creo Medical Group Plc |
CREO |
🇬🇧 |
London Stock Exchange |
£113mn |
|
| Danaher Corp. |
DHR |
🇺🇸 |
New York Stock Exchange |
$195.1bn |
S&P 500 |
| DarioHealth Corp |
DRIO |
🇺🇸 |
NASDAQ |
$35mn |
|
| DaVita Inc |
DVA |
🇺🇸 |
New York Stock Exchange |
$12.5bn |
S&P 500 |
| Demant AS |
DEMANT |
🇩🇰 |
Copenhagen Stock Exchange |
kr.55.7bn |
STOXX600 |
| DENTSPLY Sirona Inc |
XRAY |
🇺🇸 |
NASDAQ |
$5.5bn |
NASDAQ 100 S&P 500 |
| Edwards Lifesciences Corp |
EW |
🇺🇸 |
New York Stock Exchange |
$36.0bn |
S&P 500 |
| EKF Diagnostics Holdings plc |
EKF |
🇬🇧 |
London Stock Exchange |
£134mn |
|
| Elekta AB - Class B Shares |
EKTA B |
🇸🇪 |
Stockholm Stock Exchange |
kr24.8bn |
STOXX600 |
| Elevance Health Inc |
ELV |
🇺🇸 |
New York Stock Exchange |
$119.2bn |
S&P 500 |
| EssilorLuxottica |
EL |
🇫🇷 |
Euronext Paris |
€88.2bn |
Euro Stoxx 50 CAC 40 Euronext 100 STOXX600 |
| Essity Aktiebolag (publ) - Class B Shares |
ESSITY B |
🇸🇪 |
Stockholm Stock Exchange |
kr194.7bn |
STOXX600 |
| Euroapi S.A. |
EAPI |
🇫🇷 |
Euronext Paris |
€305mn |
|
| Fresenius Medical Care AG & Co. KGaA |
FME |
🇩🇪 |
Frankfurt Stock Exchange |
€10.9bn |
DAX 40 FTSE Eurotop 100 STOXX600 |
| Fresenius Medical Care AG & Co. KGaA - ADR |
FMS |
🇺🇸 |
New York Stock Exchange |
$11.9bn |
|
| Fresenius SE & Co. KGaA |
FRE |
🇩🇪 |
Frankfurt Stock Exchange |
€17.5bn |
DAX 40 STOXX600 |
| Galenica AG |
GALE |
🇨🇭 |
SIX Swiss Exchange |
Fr.3.8bn |
STOXX600 |
| Geberit AG |
GEBN |
🇨🇭 |
SIX Swiss Exchange |
Fr.19.3bn |
STOXX600 |
| Haemonetics Corp. |
HAE |
🇺🇸 |
New York Stock Exchange |
$4.6bn |
|
| HCA Healthcare Inc |
HCA |
🇺🇸 |
New York Stock Exchange |
$92.4bn |
S&P Global 100 S&P 500 |
| Henry Schein Inc. |
HSIC |
🇺🇸 |
NASDAQ |
$9.1bn |
NASDAQ 100 S&P 500 |
| Humana Inc. |
HUM |
🇺🇸 |
New York Stock Exchange |
$46.6bn |
S&P 500 |
| Inspecs Group Plc |
SPEC |
🇬🇧 |
London Stock Exchange |
£53mn |
|
| Inspiration Healthcare Group Plc |
IHC |
🇬🇧 |
London Stock Exchange |
£16mn |
|
| Intuitive Surgical Inc |
ISRG |
🇺🇸 |
NASDAQ |
$155.2bn |
NASDAQ 100 S&P 500 |
| IQVIA Holdings Inc |
IQV |
🇺🇸 |
New York Stock Exchange |
$42.3bn |
S&P 500 |
| Kromek Group Plc |
KMK |
🇬🇧 |
London Stock Exchange |
£39mn |
|
| Mediclinic International Plc |
MDC |
🇬🇧 |
London Stock Exchange |
£3.7bn |
FTSE 350 CBOE 100 CBOE 350 FTSE 250 |
| Molina Healthcare Inc |
MOH |
🇺🇸 |
New York Stock Exchange |
$19.0bn |
S&P 500 |
| National Healthcare Corp. |
NHC |
🇺🇸 |
Markets exchange |
$2.0bn |
|
| Novacyt |
ALNOV |
🇫🇷 |
Euronext Paris |
€44mn |
|
| Oragenics Inc |
OGEN |
🇺🇸 |
Markets exchange |
$5mn |
|
| Orpea S.A. |
ORP |
🇫🇷 |
Euronext Paris |
€2.1bn |
STOXX600 |
| Phibro Animal Health Corp. - Class A Shares |
PAHC |
🇺🇸 |
NASDAQ |
$383mn |
|
| PHSC |
PHSC |
🇬🇧 |
London Stock Exchange |
£3mn |
|
| Poolbeg Pharma Plc |
POLB |
🇬🇧 |
London Stock Exchange |
£63mn |
|
| Premier Inc - Class A Shares |
PINC |
🇺🇸 |
NASDAQ |
$2.1bn |
|
| Pro Medicus |
PME |
🇦🇺 |
Australian Stock Exchange |
AU$14.1bn |
|
| PureTech Health Plc |
PRTC |
🇬🇧 |
London Stock Exchange |
£415mn |
FTSE 250 FTSE 350 |
| Ramsay Health Care |
RHC |
🇦🇺 |
Australian Stock Exchange |
AU$10.7bn |
|
| Renalytix Plc |
RENX |
🇬🇧 |
London Stock Exchange |
£21mn |
|
| Resmed Inc. |
RMD |
🇺🇸 |
New York Stock Exchange |
$30.6bn |
S&P 500 |
| Resmed Inc. - Chess Depository Interest |
RMD |
🇦🇺 |
Australian Stock Exchange |
AU$46.0bn |
|
| RUA Life Sciences Plc |
RUA |
🇬🇧 |
London Stock Exchange |
£7mn |
|
| Savaria Corp. |
SIS |
🇨🇦 |
Toronto Stock Exchange |
C$1.3bn |
|
| Sensus Healthcare Inc |
SRTS |
🇺🇸 |
NASDAQ |
$104mn |
|
| Smith & Nephew plc |
SN. |
🇬🇧 |
London Stock Exchange |
£9.8bn |
FTSE 100 FTSE 350 CBOE 100 CBOE 350 STOXX600 |
| Spire Healthcare Group Plc |
SPI |
🇬🇧 |
London Stock Exchange |
£984mn |
CBOE 250 CBOE 350 FTSE 250 FTSE 350 |
| Stericycle Inc. |
SRCL |
🇺🇸 |
NASDAQ |
$5.4bn |
NASDAQ 100 |
| Straumann Holding AG |
STMN |
🇨🇭 |
SIX Swiss Exchange |
Fr.18.1bn |
STOXX600 |
| Stryker Corp. |
SYK |
🇺🇸 |
New York Stock Exchange |
$124.7bn |
S&P 500 |
| Teladoc Health Inc |
TDOC |
🇺🇸 |
New York Stock Exchange |
$1.6bn |
|
| Totally Health Plc |
TLY |
🇬🇧 |
London Stock Exchange |
£17mn |
|
| Trellus Health Plc |
TRLS |
🇬🇧 |
London Stock Exchange |
£3mn |
|
| Tristel |
TSTL |
🇬🇧 |
London Stock Exchange |
£227mn |
|
| Unitedhealth Group Inc |
UNH |
🇺🇸 |
New York Stock Exchange |
$515.1bn |
Dow Jones 30 S&P 100 S&P 500 |
| Universal Health Services, Inc. - Class B Shares |
UHS |
🇺🇸 |
New York Stock Exchange |
$12.2bn |
S&P 500 |
| Vifor Pharma AG |
VIFN |
🇨🇭 |
SIX Swiss Exchange |
Fr.10.8bn |
STOXX600 |
| Zepp Health Corporation - ADR |
ZEPP |
🇺🇸 |
New York Stock Exchange |
$18mn |
|
| Zimmer Biomet Holdings Inc |
ZBH |
🇺🇸 |
New York Stock Exchange |
$22.8bn |
S&P 500 |
| Zoetis Inc - Class A Shares |
ZTS |
🇺🇸 |
New York Stock Exchange |
$82.5bn |
S&P 500 |
